Skip to content

Improving the prognosis of dizzy elderly: a three-arm validation and intervention study in general practice

Improving the prognosis of dizzy elderly: a three-arm validation and intervention study in general practice - RODEO: reduction of dizziness in older people

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON44327
Enrollment
375
Registered
2014-09-11
Start date
2015-01-22
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duizeligheid dizziness spinning sensation

Interventions

In older patients with a high risk of persistent impairment because of dizziness we will compare a risk factor-guided intervention consisting of one, two, or three of the following interventions: (1

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - being 65 years or older - consulted a general practitioner for a new episode of dizziness, defined as recurrent dizziness for at least one month, including a giddy or rotational sensation, loss of balance, faint feeling, light-headedness, instability, or tendency to fall - current dizziness-related impairment (Dizziness Handicap Inventory score >= 30) - ability to speak, read and write Dutch

Exclusion criteria

Exclusion criteria: - severe cognitive impairment according to the patient*s GP - serious co morbidity that precludes participation in an exercise program - current enrolment in interfering study - if the patient*s GP deems participation of the patient in this study undesirable and/or if participation could damage the doctor-patient relationship for any reason. The GP*s judgement in relation to possible damage of the doctor-patient relationship will always overrule other in- or exclusion criteria.

Design outcomes

Primary

MeasureTime frame
The primary clinical outcome is dizziness related impairment at follow-up, which will be assessed using the Dizziness Handicap Inventory (DHI).

Secondary

MeasureTime frame
Secondary outcomes are quality of life (EQ-5D-5L), difference in *Fall Risk Increasing Drug* count, anxiety/depression, dizziness frequency, fall frequency, health care utilization.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)